X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1282) 1282
Publication (172) 172
Book Chapter (8) 8
Dissertation (6) 6
Book Review (4) 4
Conference Proceeding (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (866) 866
index medicus (654) 654
oncology (581) 581
cancer/testis antigens (485) 485
immunotherapy (485) 485
male (453) 453
cancer (451) 451
female (347) 347
expression (306) 306
antigens (301) 301
antigens, neoplasm - genetics (284) 284
melanoma (266) 266
antigens, neoplasm - immunology (249) 249
cancer-testis antigens (245) 245
cell line, tumor (231) 231
gene expression (231) 231
middle aged (226) 226
identification (208) 208
animals (206) 206
immunology (203) 203
antigens, neoplasm - metabolism (202) 202
cancer-testis antigen (200) 200
tumors (192) 192
aged (189) 189
cancer/testis antigen (186) 186
gene expression regulation, neoplastic (182) 182
immunohistochemistry (182) 182
genes (173) 173
dna methylation (169) 169
adult (167) 167
ny-eso-1 (166) 166
neoplasm proteins - genetics (157) 157
proteins (157) 157
prognosis (154) 154
reverse transcriptase polymerase chain reaction (152) 152
cell biology (146) 146
cancer testis antigen (139) 139
research (128) 128
protein (127) 127
gene (123) 123
mice (121) 121
genetic aspects (118) 118
biochemistry & molecular biology (116) 116
care and treatment (116) 116
analysis (115) 115
gene-expression (104) 104
dendritic cells (102) 102
family (102) 102
apoptosis (101) 101
antigens, neoplasm - biosynthesis (98) 98
breast cancer (98) 98
cytolytic t-lymphocytes (98) 98
medicine, research & experimental (97) 97
aged, 80 and over (94) 94
lymphocytes (94) 94
neoplasm proteins - metabolism (93) 93
article (92) 92
metastasis (92) 92
pathology (92) 92
testis - metabolism (92) 92
cancer testis antigens (91) 91
cells (90) 90
hematology (89) 89
breast-cancer (87) 87
health aspects (85) 85
immune-responses (82) 82
t cells (81) 81
metastatic melanoma (78) 78
methylation (77) 77
immunotherapy - methods (75) 75
lung cancer (73) 73
carcinoma (71) 71
human-melanoma (71) 71
lung-cancer (71) 71
testis - immunology (69) 69
neoplasm proteins - immunology (68) 68
vaccination (68) 68
neoplasms - immunology (67) 67
testis antigens (67) 67
cancer vaccines - immunology (66) 66
rna, messenger - genetics (66) 66
biomarkers, tumor - genetics (65) 65
mage-a (65) 65
tumor antigens (65) 65
gene expression profiling (64) 64
antigens, neoplasm - analysis (63) 63
medicine (63) 63
development and progression (62) 62
molecular sequence data (62) 62
studies (62) 62
survival (62) 62
tumor cells, cultured (62) 62
tumor-antigens (62) 62
amino acid sequence (61) 61
epigenetics (61) 61
azacitidine - pharmacology (60) 60
biomarkers (60) 60
chemotherapy (60) 60
stem cells (60) 60
immune response (59) 59
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1273) 1273
Japanese (5) 5
Russian (5) 5
French (4) 4
German (3) 3
Chinese (2) 2
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 08/2015, Volume 21, Issue 8, pp. 914 - 921
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e70522
As one of the best known cancer testis antigens, PRAME is overexpressed exclusively in germ line tissues such as the testis as well as in a variety of solid... 
MELANOMA PRAME | PREFERENTIALLY EXPRESSED ANTIGEN | MEMORY | CANCER/TESTIS ANTIGENS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | GENE-EXPRESSION | CANCER-TESTIS ANTIGEN | VERSUS-HOST-DISEASE | T-CELLS | TUMOR-ANTIGEN | T-Lymphocytes, Cytotoxic - immunology | Antigens, Neoplasm - genetics | Apoptosis - drug effects | Humans | Leukemia, Myeloid, Acute - metabolism | Azacitidine - analogs & derivatives | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | HLA-A Antigens - metabolism | Azacitidine - pharmacology | Flow Cytometry | Aminopyridines - pharmacology | HLA-A Antigens - genetics | Antigens, Neoplasm - metabolism | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Benzamides - pharmacology | Cell Cycle - drug effects | Leukemia, Myeloid, Acute - genetics | Antimitotic agents | Antigens | Epigenetic inheritance | Care and treatment | RNA | Immunotherapy | T cells | Antineoplastic agents | Cancer | Biotechnology | Histone deacetylase | Chromatin | Target recognition | CD86 antigen | Toxicity | CD8 antigen | Leukemia | Cytotoxicity | Lymphocytes T | Tissues | Lymphocytes | Cell cycle | DNA methylation | Bone marrow | Pretreatment | Deoxyribonucleic acid--DNA | Killing | Antigen presentation | Hematology | Myeloid leukemia | Melanoma | Immunosurveillance | T cell receptors | Breast cancer | Tumor cell lines | Gene expression | Inhibitors | Cell lines | Ligands | Combined treatment | Histocompatibility antigen HLA | Acute myeloid leukemia | 5-aza-2'-deoxycytidine | Deoxyribonucleic acid | DNA
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 11/2014, Volume 10, Issue 11, pp. 3153 - 3164
DNA vaccination has emerged as an attractive immunotherapeutic approach against cancer due to its simplicity, stability, and safety. Results from numerous... 
cellular immune response | IRF, interferon regulatory factor | CTLs, cytotoxic lymphocytes | SCT, single-chain trimer | CEA, carcinoembryonic antigen | HER2, Her2/neu | phTERT, optimized full-length hTERT | DNA vaccines | PMED, particle mediated epidermal delivery | CIN, cervical intraepithelial neoplasia | hTERT, human telomerase reverse transcriptase | tumor antigens | TBK1, Tank-binding kinase 1 | HSP70, heat shock protein 70 | immune tolerance | STING, stimulator of interferon genes | APCs, antigen presenting cells | Id, idiotype | DOM, fragment c domain | NHP, non-human primate | Mam-A, Mammaglobin-A | EP, electroporation | humoral immune response | TAAs, tumor-associated antigens | MHC, major histocompatibility complex | Trp2, tyrosinase related protein 2 | CT antigens, cancer-testis antigens | TLRs, Toll-like receptors | IFNs, interferons | vaccine delivery | PSMA, prostate-specific membrane antigen | PAP, Prostatic acid phosphatase | TT, tetanus toxin | GITR, glucocorticoid-induced tumor necrosis factor receptor family-related genes | Humoral immune response | Vaccine delivery | Immune tolerance | Tumor antigens | Cellular immune response | tumor-associated antigens | SCT | MHC | tetanus toxin | major histocompatibility complex | IMMUNOLOGY | prostate-specific membrane antigen | TBK1 | phTERT | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Mammaglobin-A | heat shock protein 70 | GENE-TRANSFER | CEA | neu | DOM | HSP70 | cancer-testis antigens | HUMAN TUMOR-ANTIGENS | CIN | PRESENTING CELLS | interferon regulatory factor | hTERT | IRF | human telomerase reverse transcriptase | tyrosinase related protein 2 | fragment c domain | INTRON SEQUENCE | GITR | CTLs | Trp2 | Mam-A | particle mediated epidermal delivery | glucocorticoid-induced tumor necrosis factor receptor family-related genes | Prostatic acid phosphatase | interferons | non-human primate | T-CELL RESPONSES | IMMUNE-RESPONSES | INTRAMUSCULAR INJECTION | NHP | TAAs | Toll-like receptors | antigen presenting cells | IFNs | APCs | cytotoxic lymphocytes | carcinoembryonic antigen | DENDRITIC CELLS | single-chain trimer | PROSTATIC ACID-PHOSPHATASE | cervical intraepithelial neoplasia | idiotype | optimized full-length hTERT | PSMA | stimulator of interferon genes | STING | PMED | Tank-binding kinase 1 | electroporation | HER2 | TLRs | PAP | CT antigens | Immunotherapy - methods | Antigens, Neoplasm - immunology | Dendritic Cells - immunology | Humans | Vaccination | Vaccines, DNA - immunology | Neoplasms - prevention & control | Vaccines, DNA - therapeutic use | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Animals | Neoplasms - immunology | Mice | Tumor Escape - immunology
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 11/2014, Volume 10, Issue 11, pp. 3332 - 3346
Vaccines targeting pathogens are generally effective and protective because based on foreign non-self antigens which are extremely potent in eliciting an... 
tumor-associated antigens | MS, mass spectrometry | HLA, human leukocyte antigen | PAP, prostatic acid phosphatase | APCs, antigen-presenting cell | DCs, dendritic cells | cancer vaccine | Ig Id, immunoglobulin idiotype | EGT, electro-gene-transfer | PRRs, Pattern Recognition Receptors | MVA, modified vaccinia strain Ankara | GB, glioblastoma | RCR, renal cell cancer | CDCA1, cell division cycle associated 1 | TLRs, Toll-Like Receptors | CTL, cytotoxic T-lympocites | BCG, Bacille Calmette-Guerin | TARP, T-cell receptor gamma alternate reading frame protein | hTERT, human Telomerase reverse transcriptase | IFNg, interferon gamma | clinical trials | CRC, colorectal cancer | SSX-2, Synovial sarcoma X breakpoint 2 | PSA, Prostate-specific antigen | GM-CSF, granulocyte macrophage-colony stimulating factor | TACAs, Tumor-associated carbohydrate antigens | MHC, major histocompatibility complex | TAAs, tumor-associated antigens | HPV, human papillomavirus | WGS, whole genome sequencing | NSCLC, non-small-cell lung carcinoma | epitopes | MAGE-A1, Melanoma-associated antigen 1 | LPs, long peptides | WES, whole exome sequencing | FDA, Food & drug administration | BCR, B-cell receptor | CT, Cancer-testis | HSPs, stress/heat shock proteins | HER2, human epidermal growth factor receptor 2 | immunotherapeutics | TPA, transporter associated with antigen processing | mCRPC, metastatic castrate-resistant prostate cancer | Clinical trials | Immunotherapeutics | Cancer vaccine | Epitopes | Tumor-associated antigens | T-cell receptor gamma alternate reading frame protein | WGS | MHC | cytotoxic T-lympocites | major histocompatibility complex | IMMUNOLOGY | granulocyte macrophage-colony stimulating factor | mCRPC | Toll-Like Receptors | METASTATIC MELANOMA | dendritic cells | IFNg | GM-CSF | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | electro-gene-transfer | PSA | modified vaccinia strain Ankara | colorectal cancer | interferon gamma | PULSED DENDRITIC CELLS | human Telomerase reverse transcriptase | SSX-2 | human leukocyte antigen | BCG | prostatic acid phosphatase | cell division cycle associated 1 | whole exome sequencing | whole genome sequencing | immunoglobulin idiotype | BCR | Cancer-testis | glioblastoma | ACTIVE SPECIFIC IMMUNOTHERAPY | DNA VACCINES | CRC | human papillomavirus | MVA | non-small-cell lung carcinoma | hTERT | HLA | Tumor-associated carbohydrate antigens | RCR | FDA | CDCA1 | antigen-presenting cell | WES | TPA | Prostate-specific antigen | PRRs | Bacille Calmette-Guerin | B-cell receptor | transporter associated with antigen processing | TARP | metastatic castrate-resistant prostate cancer | CYTOTOXIC T-LYMPHOCYTES | HSPs | HPV | MHC CLASS-I | HEAT-SHOCK PROTEINS | PHASE-II TRIAL | DCs | TAAs | mass spectrometry | long peptides | APCs | stress | renal cell cancer | NSCLC | Ig Id | human epidermal growth factor receptor 2 | Food & drug administration | LPs | EGT | TUMOR-CELL VACCINE | Melanoma-associated antigen 1 | TACAs | Synovial sarcoma X breakpoint 2 | MAGE-A1 | Pattern Recognition Receptors | CTL | HER2 | heat shock proteins | TLRs | PAP | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Antigens, Neoplasm - immunology | Neoplasms - immunology | Humans | Adjuvants, Immunologic - therapeutic use | Precision Medicine | Tumor Escape - immunology
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 02/2013, Volume 36, Issue 2, pp. 133 - 151
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2014, Volume 135, Issue 5, pp. 1142 - 1152
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2016, Volume 15, Issue 5, pp. 477 - 483
Journal Article